Physician

Edward Goldberger, M.D.

According to 2025 Medicare claims, Edward Goldberger, M.D. (NPI: 1194708131) practices rheumatology in the Toledo, OH market, with the plurality of this provider's patient population coming from Lucas, OH. This provider's primary affiliated billing organization is TOLEDO CLINIC INCORPORATED (NPI: 1144217894; TIN: 340936207) and primary practice location at 43606-1177. Goldberger is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Goldberger's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 330 traditional Medicare patients, billed 63,281 HCPCS/CPT codes, and received $737,075 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,737 prescription claims across 620 beneficiaries totaling $1,521,137 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 58 records totaling $33,617. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $757,227 to $1,521,137. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	457	28,600	$520,527
2016	481	30,172	$567,787
2017	490	30,736	$597,744
2018	490	37,276	$688,792
2019	475	30,505	$679,885
2020	440	30,912	$569,580
2021	458	44,412	$749,241
2022	437	51,277	$780,417
2023	387	55,762	$747,717
2024	330	63,281	$737,075

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	536	4,624	$757,227
2016	579	4,974	$835,778
2017	659	5,379	$971,859
2018	777	5,741	$1,188,543
2019	736	5,854	$1,264,443
2020	663	5,933	$1,200,060
2021	685	5,843	$1,213,219
2022	698	5,829	$1,473,538
2023	616	5,258	$1,465,761
2024	620	4,737	$1,521,137

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	295	632	$82
20610	Aspiration and/or injection of fluid from large joint	50	95	$45
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	75	116	$12
36415	Insertion of needle into vein for collection of blood sample	36	188	$9
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	66	290	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	59	1,860	$442,526
Enbrel Sureclick	Etanercept	17	700	$185,600
Orencia	Abatacept	24	672	$137,816
Xeljanz Xr	Tofacitinib Citrate	12	360	$71,490
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	408	26,451	$21,826

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	48	$1,376	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$32,241	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Edward Goldberger, M.D.?

Tedicare shows public-source Medicare data for Edward Goldberger, M.D. (NPI 1194708131), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Edward Goldberger, M.D. have ACO affiliation data?

Edward Goldberger, M.D. is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Edward Goldberger, M.D.?

Edward Goldberger, M.D. is linked to TOLEDO CLINIC INCORPORATED (billing NPI 1144217894) in the available physician profile data.

Does Edward Goldberger, M.D. have Open Payments data?

Edward Goldberger, M.D. has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.